TEVA - Teva Pharmaceutical Industries Limited

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 58.72B
Enterprise Value 336.91B
Trailing P/E N/A
Forward P/E 13.11
PEG Ratio (5 yr expected) 1-1.36
Price/Sales (ttm)0.48
Price/Book (mrq)0.59
Enterprise Value/Revenue 32.04
Enterprise Value/EBITDA 68.27

Trading Information

Stock Price History

Beta (3Y Monthly) 2.46
52-Week Change 3-66.22%
S&P500 52-Week Change 36.70%
52 Week High 325.96
52 Week Low 37.67
50-Day Moving Average 38.84
200-Day Moving Average 314.20

Share Statistics

Avg Vol (3 month) 318.49M
Avg Vol (10 day) 321.19M
Shares Outstanding 51.09B
Float 1B
% Held by Insiders 13.95%
% Held by Institutions 163.54%
Shares Short (Jun 28, 2019) 451.57M
Short Ratio (Jun 28, 2019) 42.32
Short % of Float (Jun 28, 2019) 4N/A
Short % of Shares Outstanding (Jun 28, 2019) 44.72%
Shares Short (prior month May 31, 2019) 436.1M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 12, 2017
Ex-Dividend Date 4Nov 27, 2017
Last Split Factor (new per old) 21/2
Last Split Date 3Jul 1, 2004

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin -18.66%
Operating Margin (ttm)14.85%

Management Effectiveness

Return on Assets (ttm)2.60%
Return on Equity (ttm)-20.62%

Income Statement

Revenue (ttm)18.08B
Revenue Per Share (ttm)17.40
Quarterly Revenue Growth (yoy)-15.20%
Gross Profit (ttm)8.3B
EBITDA 4.46B
Net Income Avi to Common (ttm)-3.56B
Diluted EPS (ttm)-3.42
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.97B
Total Cash Per Share (mrq)1.81
Total Debt (mrq)29.16B
Total Debt/Equity (mrq)184.32
Current Ratio (mrq)0.96
Book Value Per Share (mrq)13.50

Cash Flow Statement

Operating Cash Flow (ttm)1.06B
Levered Free Cash Flow (ttm)1.9B